Neuronetics, Inc. 8-K

What Happened

• Neuronetics, Inc. (STIM) filed an 8-K reporting several management and cost actions. On March 31, 2026, Executive VP/CFO Steven E. Pfanstiel notified the company he will resign effective May 1, 2026; the company has started a search for his successor.
• On April 1, 2026, the company and former President & CEO Keith J. Sullivan entered an Executive Consulting and Release Agreement: Mr. Sullivan will provide specified consulting services through March 31, 2027, will not receive additional consulting pay, will continue to vest in outstanding equity awards per their original terms, and agreed to customary confidentiality, non-solicitation and non-compete provisions.
• On April 2, 2026, Neuronetics initiated a workforce reduction affecting up to 5% of employees to optimize costs; the company reaffirmed financial guidance in a press release dated April 6, 2026.

Key Details

• CFO resignation effective: May 1, 2026 (Steven E. Pfanstiel).
• Consulting agreement date: April 1, 2026; consulting term through March 31, 2027; no additional cash compensation.
• Restructuring charges expected: ~ $0.2 million in Q2 2026 (severance and related costs).
• Anticipated annualized cost savings: ~$2.5 million to $3.0 million, with net savings primarily beginning in Q3 2026.

Why It Matters

• Leadership change: A CFO departure can affect near-term financial reporting and investor relations; the company is actively searching for a replacement.
• Financial impact: The one-time restructuring charge is small (~$0.2M) relative to the projected annual savings ($2.5M–$3.0M), indicating management is pursuing modest cost reductions that should improve operating results later in 2026.
• Continuity and governance: Retaining the former CEO as an unpaid consultant through March 2027, with continued equity vesting, may provide continuity during the transition.
• Guidance: The company reaffirmed prior financial guidance, which may reduce short-term uncertainty for investors.